Patents by Inventor Treena Lynne Arinzeh

Treena Lynne Arinzeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10772909
    Abstract: Shown and described is an insulin-mimetic as an inductive agent for cartilage and/or bone repair is disclosed. Sodium tungstate (Na2WO4) was utilized as an inductive factor to enhance human mesenchymal stem cell (MSC) chondrogenesis. The chondrogenic differentiation of MSCs was enhanced in the presence of low concentrations of Na2WO4 as compared to control, without Na2WO4. Also disclosed is a composite scaffold capable of supporting cell and tissue growth. The composite scaffold could include zinc oxide and polycaprolactone.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: September 15, 2020
    Assignee: New Jersey Institute of Technology
    Inventors: Treena Lynne Arinzeh, Ateka Khader
  • Publication number: 20200282109
    Abstract: The present invention provides implants useful for treating cartilage and/or osteochondral defects that comprise a plurality of scaffolds arranged in a multi-layer stacked configuration, wherein each scaffold comprises a mesh of polymer fibers and wherein the polymer fibers comprise gelatin, a plant-derived protein, e.g., zein protein, or a combination thereof. Methods for repairing a cartilage and/or an osteochondral defect using implants of the invention are also provided.
    Type: Application
    Filed: March 9, 2020
    Publication date: September 10, 2020
    Applicant: New Jersey Institute of Technology
    Inventors: Treena Lynne Arinzeh, George Collins
  • Publication number: 20200087621
    Abstract: Sodium cellulose sulfate (NaCS) is employed as a novel GAG mimetic. Schwann cells (SCs) could be used in combination with a scaffold because the SCs can secrete neurotrophic factors stimulating neuron survival and extension of axons. Furthermore, the conduit may be used alone or combination with Schwann cells for spinal cord repair. In addition, the conduit also can be used for peripheral nerve repair. Also described herein are compositions and methods useful for promoting the growth and/or differentiation and/or repair of a cell and/or tissue in the peripheral nervous system, central nervous system, and specifically the spinal cord. In certain aspects, the present disclosure includes a scaffold supporting and promoting growth, differentiation, and/or regeneration and repair. The scaffold in one embodiment closely mimics the natural extracellular matrix (ECM) of the spinal cord.
    Type: Application
    Filed: September 17, 2019
    Publication date: March 19, 2020
    Applicants: New Jersey Institute of Technology, University of Miami
    Inventors: Treena Lynne Arinzeh, Roseline Menezes, George Collins, Sharareh Hashemi, Martin Oudega
  • Patent number: 10197563
    Abstract: Disclosed is a three-dimensional (3-D) in vitro model for studying and subsequently treating cancer dormancy. The model is specifically useful in studying breast cancer and may be used for drug discovery because it maintains the breast cancer cells in a dormant state, unlike conventional two-dimensional (2-D) tissue culture plastic (TCP). Tumor-forming breast cancers cells were seeded on the 3-D model scaffolds and remained viable without proliferation. They also express stem cell markers typical for dormant cells. Dormant breast cancer cells also maintain their phenotype when seeded on the 3-D model unlike conventional 2-D models. The 3-D model includes a fibrous polycaprolactone with 30 wt. % hydroxyapatite. The 3-D model mimics the structure of bone tissue.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: February 5, 2019
    Assignees: New Jersey Institute of Technology, Rutgers, The State University of New Jersry
    Inventors: Treena Lynne Arinzeh, Pranela Rameshwar, Khadidiatou T. Guiro
  • Patent number: 10081794
    Abstract: This invention relates a structure and system for growth factor incorporation which can improve the osteogenic differentiation of hMSCs, for potential bone regeneration and bone growth applications or used alone for bone repair or growth applications. The system comprises a biodegradable polyester, a hydrophilic polymer, a growth factor and optionally a bioceramic.
    Type: Grant
    Filed: April 13, 2012
    Date of Patent: September 25, 2018
    Assignee: New Jersey Institute of Technology
    Inventors: Treena Lynne Arinzeh, Tamunotonye Briggs
  • Publication number: 20180092943
    Abstract: Shown and described is an insulin-mimetic as an inductive agent for cartilage and/or bone repair is disclosed. Sodium tungstate (Na2WO4) was utilized as an inductive factor to enhance human mesenchymal stem cell (MSC) chondrogenesis. The chondrogenic differentiation of MSCs was enhanced in the presence of low concentrations of Na2WO4 as compared to control, without Na2WO4. Also disclosed is a composite scaffold capable of supporting cell and tissue growth. The composite scaffold could include zinc oxide and polycaprolactone.
    Type: Application
    Filed: October 2, 2017
    Publication date: April 5, 2018
    Inventors: Treena Lynne Arinzeh, Ateka Khader
  • Publication number: 20170252487
    Abstract: The present disclosure generally relates to a composite scaffold containing insulin-mimetic materials for healing bone defects (e.g., bone repair). In particular, the present disclosure relates to a fibrous composite containing a synthetic polymer, nanoceramic and a vanadium salt to improve the healing of bone defects.
    Type: Application
    Filed: March 2, 2017
    Publication date: September 7, 2017
    Applicant: New Jersey Institute of Technology
    Inventors: Treena Lynne Arinzeh, Svetlana Dukleska-Schussler
  • Publication number: 20170131273
    Abstract: Disclosed is a three-dimensional (3-D) in vitro model for studying and subsequently treating cancer dormancy. The model is specifically useful in studying breast cancer and may be used for drug discovery because it maintains the breast cancer cells in a dormant state, unlike conventional two-dimensional (2-D) tissue culture plastic (TCP). Tumor-forming breast cancers cells were seeded on the 3-D model scaffolds and remained viable without proliferation. They also express stem cell markers typical for dormant cells. Dormant breast cancer cells also maintain their phenotype when seeded on the 3-D model unlike conventional 2-D models. The 3-D model includes a fibrous polycaprolactone with 30 wt. % hydroxyapatite. The 3-D model mimics the structure of bone tissue.
    Type: Application
    Filed: November 10, 2016
    Publication date: May 11, 2017
    Inventors: Treena Lynne Arinzeh, Pranela Rameshwar, Khadidiatou T. Guiro
  • Patent number: 9181636
    Abstract: The present invention relates to compositions and methods of preparing a three-dimensional matrix of micron sized electrospun fibers, wherein the electrospun fibers are formed from a electrospun composite comprising a bioactive ceramic component and a polymer component. The matrix provides an osteoconductive and osteoinductive scaffold supporting osteogenesis and thereby facilitates bone repair.
    Type: Grant
    Filed: August 16, 2011
    Date of Patent: November 10, 2015
    Assignee: New Jersey Institute of Technology
    Inventor: Treena Lynne Arinzeh
  • Publication number: 20150087062
    Abstract: This invention relates a structure and system for growth factor incorporation which can improve the osteogenic differentiation of hMSCs, for potential bone regeneration and bone growth applications or used alone for bone repair or growth applications. The system comprises a biodegradable polyester, a hydrophilic polymer, a growth factor and optionally a bioceramic.
    Type: Application
    Filed: April 13, 2012
    Publication date: March 26, 2015
    Inventors: Treena Lynne Arinzeh, Tamunotonye Briggs
  • Publication number: 20110300626
    Abstract: The present invention relates to compositions and methods of preparing a three-dimensional matrix of micron sized electrospun fibers, wherein the electrospun fibers are formed from a electrospun composite comprising a bioactive ceramic component and a polymer component. The matrix provides an osteoconductive and osteoinductive scaffold supporting osteogenesis and thereby facilitates bone repair.
    Type: Application
    Filed: August 16, 2011
    Publication date: December 8, 2011
    Applicant: NEW JERSEY INSTITUTE OF TECHNOLOGY
    Inventor: Treena Lynne Arinzeh
  • Publication number: 20090028921
    Abstract: The present invention relates to compositions and methods of preparing a three-dimensional matrix of micron sized electrospun fibers, wherein the electrospun fibers are formed from a electrospun composite comprising a bioactive ceramic component and a polymer component. The matrix provides an osteoconductive and osteoinductive scaffold supporting osteogenesis and thereby facilitates bone repair.
    Type: Application
    Filed: June 18, 2008
    Publication date: January 29, 2009
    Applicant: New Jersey Institute Of Technology
    Inventor: Treena Lynne Arinzeh